Guido Zaman and Suzanne van Gerwen will attend and present at the 8th International Conference on Protein Kinase Inhibitors (IPK2014) held in Warsaw, Poland, from September 21st to 25th.
The distinguished list of speakers at the conference includes Professor Dr. Kevan Shokat from the University of California, Professor Dr. Stephan Knapp from the University of Oxford and forty other leaders in the field of kinase inhibitor research from academia and drug discovery companies.
On Monday, September 22nd, Guido Zaman will present on the identification of genomic drug sensitivity markers and new synergistic drug combinations by using NTRC’s cancer cell line panel, Oncolines™, in a session entitled “PKs in action” and chaired by Dr. Doriano Fabbro from Piqur Therapeutics A.G. and Prof. Dr. Lorenzo Pinna from the University of Padua.
During the conference Guido Zaman and Suzanne van Gerwen will also present two posters: one on ResidenceTimer™ and one on SynergyFinder™.
Title of the presentation:
“Identification of genomic drug sensitivity markers and new synergistic drug combinations by cancer cell line profiling”
Titles of posters:
“Next generation kinase panel screening measuring target residence time and kinetic selectivity”
“Identification of new synergistic kinase inhibitor drug combinations on the basis of cell panel profiling”
For more information on NTRC’s kinase drug discovery programs, please contact: [email protected].
For more information on NTRC Services, please contact: [email protected]or call +31 412 700 501